A detailed history of Sei Investments CO transactions in Novo Nordisk A S stock. As of the latest transaction made, Sei Investments CO holds 661,752 shares of NVO stock, worth $56.2 Million. This represents 0.11% of its overall portfolio holdings.

Number of Shares
661,752
Previous 718,784 7.93%
Holding current value
$56.2 Million
Previous $103 Million 23.2%
% of portfolio
0.11%
Previous 0.15%

Shares

31 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

SELL
$119.07 - $145.42 $6.79 Million - $8.29 Million
-57,032 Reduced 7.93%
661,752 $78.8 Million
Q2 2024

Aug 13, 2024

SELL
$122.71 - $146.91 $4.42 Million - $5.29 Million
-35,992 Reduced 4.77%
718,784 $103 Million
Q1 2024

May 07, 2024

SELL
$102.11 - $135.92 $5.38 Million - $7.16 Million
-52,662 Reduced 6.52%
754,776 $96.9 Million
Q4 2023

Feb 14, 2024

BUY
$87.78 - $105.45 $2.52 Million - $3.03 Million
28,723 Added 3.69%
807,438 $83.5 Million
Q3 2023

Nov 14, 2023

BUY
$90.94 - $199.54 $48.9 Million - $107 Million
537,582 Added 222.94%
778,715 $70.8 Million
Q2 2023

Aug 11, 2023

BUY
$155.98 - $172.65 $2.26 Million - $2.5 Million
14,471 Added 6.38%
241,133 $39 Million
Q1 2023

May 12, 2023

BUY
$132.34 - $159.14 $685,785 - $824,663
5,182 Added 2.34%
226,662 $36.1 Million
Q4 2022

Feb 10, 2023

BUY
$102.55 - $135.33 $2.8 Million - $3.7 Million
27,318 Added 14.07%
221,480 $30 Million
Q3 2022

Nov 14, 2022

SELL
$95.28 - $116.93 $1.34 Million - $1.65 Million
-14,090 Reduced 6.77%
194,162 $19.3 Million
Q2 2022

Aug 15, 2022

BUY
$103.24 - $121.81 $10.4 Million - $12.3 Million
101,077 Added 94.31%
208,252 $23.1 Million
Q1 2022

May 13, 2022

BUY
$93.1 - $112.54 $1.49 Million - $1.8 Million
15,996 Added 17.54%
107,175 $11.9 Million
Q4 2021

Feb 14, 2022

SELL
$95.88 - $117.08 $252,260 - $308,037
-2,631 Reduced 2.8%
91,179 $10.2 Million
Q3 2021

Nov 12, 2021

SELL
$84.42 - $106.62 $1.52 Million - $1.92 Million
-17,990 Reduced 16.09%
93,810 $9.01 Million
Q2 2021

Aug 06, 2021

BUY
$67.66 - $84.76 $1.98 Million - $2.48 Million
29,289 Added 35.5%
111,800 $9.37 Million
Q1 2021

May 12, 2021

SELL
$67.06 - $75.82 $1.31 Million - $1.48 Million
-19,469 Reduced 19.09%
82,511 $5.56 Million
Q4 2020

Feb 08, 2021

SELL
$63.89 - $73.8 $769,555 - $888,921
-12,045 Reduced 10.56%
101,980 $7.12 Million
Q3 2020

Dec 04, 2020

SELL
$63.69 - $70.22 $589,323 - $649,745
-9,253 Reduced 7.51%
114,025 $7.92 Million
Q3 2020

Nov 06, 2020

SELL
$63.69 - $70.22 $1.14 Million - $1.26 Million
-17,936 Reduced 12.7%
123,278 $8.56 Million
Q2 2020

Aug 17, 2020

SELL
$58.54 - $67.94 $1.29 Million - $1.5 Million
-22,094 Reduced 13.53%
141,214 $9.25 Million
Q2 2020

Aug 11, 2020

BUY
$58.54 - $67.94 $306,164 - $355,326
5,230 Added 3.31%
163,308 $9.51 Million
Q1 2020

May 14, 2020

BUY
$49.46 - $64.78 $39,716 - $52,018
803 Added 0.51%
158,078 $9.52 Million
Q4 2019

Feb 06, 2020

SELL
$49.86 - $58.26 $1.07 Million - $1.25 Million
-21,534 Reduced 12.04%
157,275 $9.1 Million
Q3 2019

Nov 12, 2019

SELL
$47.54 - $53.43 $491,611 - $552,519
-10,341 Reduced 5.47%
178,809 $9.24 Million
Q2 2019

Aug 14, 2019

SELL
$46.79 - $52.47 $320,885 - $359,839
-6,858 Reduced 3.5%
189,150 $9.66 Million
Q1 2019

May 15, 2019

BUY
$46.36 - $52.63 $7.72 Million - $8.76 Million
166,457 Added 563.29%
196,008 $10.3 Million
Q4 2018

Feb 13, 2019

BUY
$41.54 - $47.25 $20,770 - $23,625
500 Added 1.72%
29,551 $1.39 Million
Q3 2018

Nov 08, 2018

SELL
$46.76 - $51.24 $2.7 Million - $2.95 Million
-57,647 Reduced 66.49%
29,051 $1.37 Million
Q2 2018

Aug 03, 2018

SELL
$44.29 - $50.42 $646,678 - $736,182
-14,601 Reduced 14.41%
86,698 $4 Million
Q1 2018

May 11, 2018

BUY
$48.49 - $58.14 $399,751 - $479,306
8,244 Added 8.86%
101,299 $4.99 Million
Q4 2017

Feb 08, 2018

BUY
$47.53 - $53.73 $3.54 Million - $4.01 Million
74,546 Added 402.76%
93,055 $4.99 Million
Q3 2017

Nov 06, 2017

BUY
$41.15 - $49.22 $761,645 - $911,012
18,509
18,509 $891,000

Others Institutions Holding NVO

About NOVO NORDISK A S


  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $192B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track Sei Investments CO Portfolio

Follow Sei Investments CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sei Investments CO, based on Form 13F filings with the SEC.

News

Stay updated on Sei Investments CO with notifications on news.